From: https://doi.org/10.1016/j.neurom.2025.01.013
My colleague Nicolás Barabino of Adcorpus called my attention to a recent publication by Nine Continents Medical reporting on Coloplast’s Intibia™ System, which is an implantable tibial nerve stimulator in subjects with urgency urinary incontinence.
Nine Continents Medical was founded in Livermore, CA in 2014. It was acquired in 2020 by ostomy company Coloplast acquired for $145M upfront cash payment and an additional contingent future milestone payment. The acquisition gave Coloplast an early-stage implantable tibial nerve stimulation treatment for over-active bladder.
The Intibia™ implantable tibial nerve stimulator (ITNS) is a miniaturized, self-powered unit placed in the lower leg under local anesthesia during a short, minimally invasive procedure. It is claimed to have long battery life, with no need for patient compliance in therapy. Continue reading